“Pioneering study looks at p53's role in tumor-stroma interactions”
(Oct 25) EurekAlert! reports, “Atlanta, GA-Researchers at Emory University's Winship Cancer Institute have conducted the first comprehensive study of the role an important tumor suppressor gene plays in cancer development.“
“Free Training on Genomic Resources During American Heart Association's Scientific Sessions 2006”
(Oct 25) PR Web reports, “OpenHelix will be presenting four free tutorials on the most popular and powerful publicly accessible, web-based genomics resources during American Heart Association's Scientific Sessions 2006 in Chicago, November 12-14.”
“Unraveling the Listeria Genome”
(Oct 24) USDA reports, “If knowledge is power, researchers are gaining the upper hand over Listeria monocytogenes, a pathogen that causes listeriosis.”
“Genetic variation impacts aspirin's effectiveness in preventing colon cancer, Dartmouth study finds”
(Oct 24) Dartmouth News reports, “Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.”
“Amgen, Brigham and Women's Hospital, NIH to launch women's health genome study”
(Oct 24) News-Medical.Net reports, “Biotechnology company Amgen, Boston-based Brigham and Women's Hospital and NIH plan to launch the Women's Health Genome Study -- which aims to discover the genetic causes of disorders affecting women, including breast cancer -- the Wall Street Journal reports.”
“Genetic Disorder Linked To Rapid Lung Function Decline In Some World Trade Center Rescue
Workers”
(Oct 24) Medical News Today reports, “A rare genetic disorder known as alpha-1 antitrypsin (A1AT) deficiency may predispose patients to developing lung conditions, but a new rapid-response test could help identify patients with the deficiency before significant lung damage has occurred.”
“Diabetes gene carries similar risk to obesity”
(Oct 23) EurekAlert! reports, “Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.”
“Huntington's gene has led to clues, but not yet cures”
(Oct 23) The Boston Globe reports, “When Todd Bliss was 19 and found out that he almost surely faced the degenerative death sentence of Huntington's disease, there was no treatment, no cure -- nothing even close.”
“Genetic Repair Mechanism Clears The Way For Sealing DNA Breaks”
(Oct 20) Medical News Today reports, “Scientists investigating an important DNA-repair enzyme now have a better picture of the final steps of a process that glues together, or ligates, the ends of DNA strands to restore the double helix.”
“Insights into activity-dependent neuronal growth through RSRF-supported research”
(Oct 20) EurekAlert! reports, “Brain-derived neurotrophic factor (BDNF) has been a subject of keen interest in neuroscientific circles for several years, turning up in studies of conditions ranging from central hypoventilation syndrome to obsessive-compulsive disorder, depression, bipolar disorder and schizophrenia -- a range of disorders uncannily parallel to those produced by mutations in the "Rett gene," MeCP2.”
“Affymetrix 500K array used to identify memory gene”
(Oct 19) EurekAlert! reports, “Affymetrix Inc. announced today that researchers at the Translational Genomics Research Institute in Phoenix, Arizona have used the Affymetrix 500K Array to discover a gene--called Kibra--associated with memory performance in humans.”
“NCI Releases Preliminary Data on Genetic Susceptibility for Prostate Cancer”
(Oct 19) NIH News reports, “The National Cancer Institute (NCI), part of the National Institutes of Health, has released new data from the Cancer Genetic Markers of Susceptibility (CGEMS) study on prostate cancer.”